Kiwa Bio-Tech Products Group Corp (fka KWBT)

[operating_line]

With Kiwa Biotech products being deployed in established sales networks in China by experienced players and a plan for production expansion of the higher margin core microbial product, we need to hear on what the new sales guidance attributed to KWBT will be in the cooperation to give KWBT shareholders some targets above the 2019 base case of $40million, in addition to the promised release of the 3 quarters of financials. Plenty to digest.